Pure Health Holding

1. Company Overview & Earnings Context

PureHealth Holding PJSC is the UAE's largest integrated healthcare group, operating hospitals, diagnostics, procurement, technology, and health insurance businesses across the UAE, UK, Greece and Cyprus. The Group delivered a strong H1 2026 performance, driven by continued momentum across its Care and Cover verticals, higher contributions from international operations following the consolidation of Hellenic Healthcare Group (HHG), improving patient activity, and stronger operating leverage.

2. Financial Performance Snapshot

• Revenue: AED 14.85 Billion

• Gross Profit: AED 3.62 Billion

• EBITDA: AED 2.87 Billion

• Operating Expenses (G&A + Selling & Distribution): AED 2.34 Billion

• Finance Costs: AED 469.1 Million

• Other Operating Income: AED 580.9 Million

• Profit Before Tax: AED 1.40 Billion

• Income Tax Expense: AED 166.7 Million

• Net Profit: AED 1.24 Billion

• Basic & Diluted EPS: AED 0.11

Compared with H1 2025:

• Revenue increased 9.4% to AED 14.85 billion.

• Gross profit increased 9.4% to AED 3.62 billion.

• EBITDA increased 23.9% to AED 2.87 billion.

• Profit before tax increased 19.4% to AED 1.40 billion.

• Net profit increased 20.1% to AED 1.24 billion.

• EPS increased from AED 0.09 to AED 0.11.

3. Operational Highlights & Key Metrics

• Total Assets: AED 57.2 Billion

• Total Equity: AED 18.8 Billion

• Cash & Bank Balances: AED 4.73 Billion

• Patient Interactions: 6.1 Million

• Operational Beds: 6,900

• Inpatient Volume: 163,000

• Outpatient Volume: 5.44 Million

• UAE Test Volumes: 16.2 Million

• Gross Written Premium (GWP): AED 5.5 Billion

• Daman Active Members: 3.4 Million

• International Care (HHG) contributed AED 1.6 Billion in revenue during H1 2026.

4. Key Performance Drivers

PureHealth's H1 2026 performance was supported by broad-based growth across its Care and Cover businesses. Revenue benefited from the consolidation of Hellenic Healthcare Group, continued growth at Circle Health Group, stronger patient activity across UAE operations, and sustained momentum in Daman through policy renewals, disciplined pricing and new customer acquisition. Higher-margin international operations, improving operating leverage, cost discipline and expanding utilisation across hospitals and specialist services contributed to significant EBITDA and profit growth.

5. Outlook & Forward Guidance

Management expects to build on the stronger momentum achieved during the second quarter by further integrating and scaling its international operations, capturing synergies across the Group, investing in technology, automation and advanced clinical capabilities, and continuing to diversify earnings across geographies. The Group remains focused on delivering sustainable long-term value through its integrated healthcare and insurance platform.

6. Investor Takeaway

PureHealth delivered another strong set of results in H1 2026, combining solid revenue growth with faster earnings expansion and improved margins. Supported by growing international operations, a resilient insurance business, expanding healthcare capacity, and continued investment in technology and clinical excellence, the Group remains well positioned for sustainable long-term growth.